Intuitive Surgical, Inc. (NASDAQ: ISRG) is predicted to report its second-quarter earnings subsequent week, amid expectations for sturdy income and revenue progress. The medical gadget maker is flourishing on the widespread shift to minimally invasive surgical procedures globally, a development that’s anticipated to assemble additional momentum within the coming years.
Shares of Intuitive Surgical have gained a whopping 32% this 12 months and hit a brand new excessive two weeks in the past. Staying on an upward spiral since October final 12 months, ISRG is likely one of the best-performing Wall Avenue shares. Even after the sturdy grains, the blue-chip inventory stays a compelling funding possibility, because of the distinctive portfolio led by the corporate’s flagship da Vinci robotic surgical methods, which stays a preferred alternative for minimally invasive surgical procedures.
Outlook
Intuitive Surgical’s sturdy fundamentals and the speedy adoption of its gadgets justify the comparatively excessive valuation. With every gadget sale, the corporate secures recurring revenues from the supply of equipment and different providers throughout the contract interval. Because the firm is working to combine new options based mostly on AI and machine studying applied sciences, its methods are anticipated to play a a lot greater function in performing procedures with a excessive stage of precision, thereby considerably enhancing affected person outcomes.
Lately, the superior fifth-generation da Vinci system obtained FDA clearance. Market watchers are bullish of their outlook on surgical robots and forecast continued sturdy demand progress, which bodes nicely for the corporate. After making a robust begin to fiscal 2024, Intuitive Surgical seems to be poised to repeat the spectacular efficiency it delivered within the first quarter.
The second-quarter report is predicted to be launched on Thursday, July 18, at 4:05 pm ET. The consensus earnings estimate for Q2 2024 is $1.54 per share, up 8.5% from the revenue the corporate earned within the year-ago quarter. The constructive outlook represents an estimated 13.4% income progress to $1.97 billion within the June quarter.
Key Metrics
Final fiscal 12 months, the corporate’s revenue, on a per-share foundation, beat estimates each quarter and the development continued in early 2024. First-quarter adjusted revenue climbed 22% year-over-year to $1.50 per share. At $1.89 billion, revenues have been up 11% year-over-year and barely above specialists’ projections. Devices & Equipment, which symbolize almost 60% of revenues, grew a powerful 18%. Worldwide da Vinci procedures continued to develop in double digits, whereas the put in methods base climbed to a brand new excessive.
From Intuitive Surgical’s Q1 2024 earnings name:
“The primary quarter of 2024 was a stable one for Intuitive, the place core measures of our enterprise stay wholesome together with stable process progress and capital placements. Moreover, our groups delivered necessary milestones throughout a number of components of our Intuitive ecosystem, together with launching our next-generation multiport platform, da Vinci 5, launching our da Vinci SP platform in Europe, and enhancing our provide constraints for Ion catheters… Taken collectively, we stay keen about our alternative and we’ll work via near-term pressures by specializing in what we are able to management.”
The inventory worth almost doubled up to now two years and incessantly outperformed the market throughout that interval. ISRG traded at round $445 on Friday afternoon.
